Product Information
AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE is a brand product labeled by Mannkind Corporation, priced at $5.1957 per EA under NDC 47918087490. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
4 [arb'U]/1
Manufacturer
Mannkind CorporationNDC
47918087490
Classification
Brand
Dosage Form
POWDER, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
4/1/2026
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA022472On Market Since
1/21/2015
Pharmacological Classes
Price Statistics
The NADAC for AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1957 per EA |
|---|---|
| All-time high | $5.1957 (Jun 24, 2026) |
| All-time low | $4.7996 (Apr 17, 2024) |
| 52-week high | $5.1957 |
| 52-week low | $5.0468 |
| Median price | $5.0583 |
| Average price | $4.9989 |
| Largest weekly change | +5.0% (Dec 18, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the INSULIN HUMAN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE?
The current National Average Drug Acquisition Cost (NADAC) for AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE, manufactured by Mannkind Corporation, is $5.1957 per EA (NDC 47918087490), effective Jun 24, 2026.
How has the price of AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE changed over time?
Over the history we have for it, the NADAC for AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE has risen 8.3%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE?
Since Apr 17, 2024, the NADAC for AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE has ranged from a low of $4.7996 (Apr 17, 2024) to a high of $5.1957 (Jun 24, 2026), with a median of $5.0583 per EA.
Are there cheaper alternatives to AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE, so no direct lower-cost alternative is listed.
Who manufactures AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE?
AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE (NDC 47918087490) is labeled by Mannkind Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification